Health

Exagen

$15.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.67 (+4.56%) Today
$0.00 (0.00%) As of 11:01 PM UTC after-hours

Why Robinhood?

You can buy or sell Exagen and other stocks, options, and ETFs commission-free!

About XGN

Exagen Inc. Common Stock, also called Exagen, is a commercial-stage diagnostics company. It engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. The company operates under the Avise brand. Exagen was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA. The listed name for XGN is Exagen Inc. Common Stock.

CEO
Fortunato Ron Rocca
Employees
156
Headquarters
Vista, California
Founded
2002
Market Cap
191.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
30.80K
High Today
$15.95
Low Today
$14.51
Open Price
$14.51
Volume
10.21K
52 Week High
$24.98
52 Week Low
$10.29

Collections

XGN Earnings

-$2.40
-$1.60
-$0.80
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 24, After Hours

You May Also Like

SGH
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure